| Gene Testing
What about gene testing?
There is a test for mutations in the CDKN2A gene and GenoMEL uses such a test in its research. This work is vital to understanding melanoma and finding better ways of preventing and treating it.
Testing is also available clinically (as part of individual treatment) in several countries including the USA.
We feel routine testing of family members might be premature. Why?
A negative test result might only mean a family possesses other high-risk genes for melanoma that we have yet to identify.
With the information we currently have it is difficult to say exactly what the chances of developing a melanoma are with a positive test.
A positive test would not really change a person’s treatment or care. Patients should still see their specialist regularly and be advised to practise sun protection.
A positive test might have an impact on insurance premiums.
 |